Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAN-BIOPSY: Neurobiological Markers in MDD and Anxiety
NCT01477203Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2011
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), anxiety disorder, sponsored by Medical University of Vienna. Started Nov 2011; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT01477203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01477203.